{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:00:38Z","timestamp":1785416438209,"version":"3.56.0"},"reference-count":27,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"MOHW | Taiwan Centers for Disease Control","award":["MOHW109-CDC-C-315-114403,MOHW110-CDC-C-315-11440,MOHW111-CDC-C- 315-124305,MOHW112-CDC-C-315-134305"],"award-info":[{"award-number":["MOHW109-CDC-C-315-114403,MOHW110-CDC-C-315-11440,MOHW111-CDC-C- 315-124305,MOHW112-CDC-C-315-134305"]}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Cycloserine (CS) is a widely used drug for drug-resistant tuberculosis (DR-TB) treatment. The World Health Organization (WHO) recently suggested a critical concentration (CC) for CS using the MGIT 960 system (MGIT). To strengthen our DR-TB management program, we performed CS resistance analyses to provide comprehensive drug susceptibility testing (DST). This retrospective study included\n                      <jats:italic toggle=\"yes\">Mycobacterium tuberculosis<\/jats:italic>\n                      complex (MTBC) isolates obtained from 114 rifampin-resistant (RR) and multidrug-resistant (MDR) TB cases. We compared the results of phenotypic DST (pDST) and genotypic DST (gDST) and evaluated the minimum inhibitory concentration (MIC) using both MGIT and the Sensititre MYCOTB MIC Plate (Sensititre). Sanger sequencing and whole-genome sequencing were conducted to analyze the mutations of CS-resistant-associated\n                      <jats:italic toggle=\"yes\">ald<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">alr<\/jats:italic>\n                      genes. Our results indicated that the optimal consistency with gDST was achieved with the CC of 16 \u00b5g\/mL for MGIT, which aligns with the WHO recommendations, and the CC of 8 \u00b5g\/mL for Sensititre. Of the 114 MTBC isolates, we found 5 (4.4%) CS-MGIT-resistant isolates, which all harbored mutations in the\n                      <jats:italic toggle=\"yes\">alr<\/jats:italic>\n                      gene, including three previously known mutations M343T, T20M, L113R, and a novel mutation R243S, whereas seven low-MIC isolates harboring\n                      <jats:italic toggle=\"yes\">alr<\/jats:italic>\n                      Q30R mutations might not be associated with CS resistance. Notably, M1I, E118K, and A184T in the\n                      <jats:italic toggle=\"yes\">ald<\/jats:italic>\n                      gene and L113R, R243S, S261N, and M343T in the\n                      <jats:italic toggle=\"yes\">alr<\/jats:italic>\n                      gene were predicted to have a destabilizing effect, which could interfere with protein functions and induce drug resistance. For accurate routine diagnosis of CS susceptibility, we adopted the CC of 16 \u00b5g\/mL and suggested an interim 8 \u00b5g\/mL using MGIT and Sensititre, respectively.\n                    <\/jats:p>\n                    <jats:sec>\n                      <jats:title>IMPORTANCE<\/jats:title>\n                      <jats:p>\n                        To strengthen the DR-TB management program in Taiwan, we performed cycloserine (CS) resistance analyses to enhance treatment outcomes. Of the 114 drug-resistant tuberculosis (DR-TB) isolates, we found 5 (4.4%) CS-MGIT-resistant isolates, with four isolates classified as multidrug-resistant (MDR)-TB and one isolate as Pre-XDR-TB. In addition, we observed all CS-MGIT-resistant isolates harbored mutations in the\n                        <jats:italic toggle=\"yes\">alr<\/jats:italic>\n                        gene, including three previously known high-confidence mutations M343T, T20M, and L113R, as well as the novel R243S mutation. We also found that mutations could lead to CS resistance by disrupting protein stability.\n                      <\/jats:p>\n                    <\/jats:sec>\n                  <\/jats:sec>","DOI":"10.1128\/spectrum.03422-24","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T09:00:40Z","timestamp":1749459640000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["Cycloserine resistance among drug-resistant tuberculosis cases in Taiwan"],"prefix":"10.1128","volume":"13","author":[{"given":"Sheng-Han","family":"Wu","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00vxgjw72","id-type":"ROR","asserted-by":"publisher"}],"name":"Tuberculosis Research Center, Centers for Disease Control, Ministry of Health and Welfare","place":["Taipei, Taiwan"]},{"id":[{"id":"https:\/\/ror.org\/00vxgjw72","id-type":"ROR","asserted-by":"publisher"}],"name":"Reference Laboratory of Mycobacteriology, Centers for Disease Control, Ministry of Health and Welfare","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Yi","family":"Liu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00vxgjw72","id-type":"ROR","asserted-by":"publisher"}],"name":"Tuberculosis Research Center, Centers for Disease Control, Ministry of Health and Welfare","place":["Taipei, Taiwan"]},{"id":[{"id":"https:\/\/ror.org\/00vxgjw72","id-type":"ROR","asserted-by":"publisher"}],"name":"Reference Laboratory of Mycobacteriology, Centers for Disease Control, Ministry of Health and Welfare","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5537-3005","authenticated-orcid":false,"given":"Kuang-Hung","family":"Liu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00vxgjw72","id-type":"ROR","asserted-by":"publisher"}],"name":"Tuberculosis Research Center, Centers for Disease Control, Ministry of Health and Welfare","place":["Taipei, Taiwan"]},{"id":[{"id":"https:\/\/ror.org\/00vxgjw72","id-type":"ROR","asserted-by":"publisher"}],"name":"Reference Laboratory of Mycobacteriology, Centers for Disease Control, Ministry of Health and Welfare","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hseuh-Chien","family":"Hsiao","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00vxgjw72","id-type":"ROR","asserted-by":"publisher"}],"name":"Tuberculosis Research Center, Centers for Disease Control, Ministry of Health and Welfare","place":["Taipei, Taiwan"]},{"id":[{"id":"https:\/\/ror.org\/00vxgjw72","id-type":"ROR","asserted-by":"publisher"}],"name":"Reference Laboratory of Mycobacteriology, Centers for Disease Control, Ministry of Health and Welfare","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9378-6801","authenticated-orcid":true,"given":"Ruwen","family":"Jou","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00vxgjw72","id-type":"ROR","asserted-by":"publisher"}],"name":"Tuberculosis Research Center, Centers for Disease Control, Ministry of Health and Welfare","place":["Taipei, Taiwan"]},{"id":[{"id":"https:\/\/ror.org\/00vxgjw72","id-type":"ROR","asserted-by":"publisher"}],"name":"Reference Laboratory of Mycobacteriology, Centers for Disease Control, Ministry of Health and Welfare","place":["Taipei, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","unstructured":"World Health Organization. 2024. Global tuberculosis report 2024"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.3109\/14756366.2015.1050010"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-020-0498-9"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12074-z"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3548"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01575-17"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33370-6"},{"key":"e_1_3_3_9_2","unstructured":"World Health Organization. 2024. WHO operational handbook on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection 3rd ed"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00080614"},{"key":"e_1_3_3_11_2","unstructured":"World Health Organization. 2018. Technical manual for drug susceptibility testing of medicines used in the treatment of tuberculosis"},{"key":"e_1_3_3_12_2","volume-title":"M24\u2013A2. Susceptibility testing of mycobacteria, Nocardia spp., and other aerobic actinomycetes","author":"Clinical and Laboratory Standards Institute (ed)","year":"2018","unstructured":"Clinical and Laboratory Standards Institute (ed). 2018. M24\u2013A2. Susceptibility testing of mycobacteria, Nocardia spp., and other aerobic actinomycetes. 3rd ed","edition":"3"},{"key":"e_1_3_3_13_2","unstructured":"World Health Organization. 2020. Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-022-08291-4"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0650-x"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btt691"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/pro.3942"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad472"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2012.031"},{"key":"e_1_3_3_20_2","volume-title":"Biostatistical analysis","author":"Zar JH","year":"1999","unstructured":"Zar JH. 1999. Biostatistical analysis. Pearson Education India."},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy624"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.05.030"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-11795-4"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.2001.tb10547.x"},{"key":"e_1_3_3_25_2","unstructured":"World Health Organization. 2019. WHO consolidated guidelines on drug-resistant tuberculosis treatment"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01182"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S348428"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx316"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.03422-24","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.03422-24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:06:14Z","timestamp":1751360774000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.03422-24"}},"subtitle":[],"editor":[{"given":"Siu-Kei","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1128\/spectrum.03422-24"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.03422-24","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"2025-01-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e03422-24"}}